ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -20 مورد

Medications that may affect bronchoprovocation challenge test[1-3]

Medications that may affect bronchoprovocation challenge test[1-3]
Medication Minimum time to omit medication before challenge tests
Inhaled bronchodilators
Albuterol 6 hours
Levalbuterol 6 hours
Terbutaline 6 hours
Formoterol, salmeterol 36 hours
Ultra long-acting beta agonists (eg, indacaterol, olodaterol, vilanterol) 48 hours
Short-acting muscarinic antagonist (ipratropium) 12 hours
Long-acting muscarinic antagonists (aclidinium, glycopyrrolate, tiotropium) 1 week
Oral theophylline 24 hours
Oral albuterol 12 to 24 hours
Oral glucocorticoid* 2 to 3 weeks
Cromolyn sodium 4 hours
Leukotriene modifiers (not typically withheld)Δ 4 weeks
Inhaled glucocorticoids (not typically withheld)Δ 4 weeks

* The authors do not recommend routinely withholding oral glucocorticoids, but their anti-inflammatory effect may decrease bronchial responsiveness. A negative test while the patient is using glucocorticoids suggests that the patient's current symptoms are not due to asthma.

¶ Cromolyn has minimal effect on methacholine bronchoprovocation challenge, but should be withheld prior to allergen challenge.

Δ A single dose of inhaled glucocorticoids or leukotriene modifiers has minimal effect on methacholine challenge, but a withhold time of 4 to 8 weeks would be needed for full resolution of the anti-inflammatory effects. Negative testing on controller therapy suggests that the patient's current symptoms are not due to asthma.
References:
  1. Weiler JM, Brannan JD, Randolph CC, et al. Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol 2016; 138: 1292-1295.
  2. Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J 2017; 49.
  3. Hallstrand TS, Leuppi JD, et al. ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J 2018; 52:1801033.
Graphic 62151 Version 11.0